Lexeo Therapeutics (LXEO) Total Liabilities (2022 - 2026)
Lexeo Therapeutics (LXEO) posted Total Liabilities of $18.9 million for Q1 2026, down 14.35% sequentially from $22.0 million in Q4 2025, and down 49.81% YoY from $37.6 million in Q1 2025.
Lexeo Therapeutics (LXEO) Total Liabilities (2022 - 2026) Analysis & Trends
Lexeo Therapeutics has reported Total Liabilities for 5 years, with the latest figure at $18.9 million in Q1 2026.
- Quarterly Total Liabilities fell 49.81% year-over-year to $18.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.9 million (down 49.81% YoY) and the FY2025 annual result came in at $22.0 million, down 26.85% from the prior year.
- Total Liabilities slipped to $18.9 million in Q1 2026 per LXEO's latest filing, from $22.0 million in the prior quarter.
- Over five years, Total Liabilities peaked at $37.8 million in Q2 2025 and troughed at $18.9 million in Q1 2026.
- A 5-year average of $28.8 million and a median of $28.6 million in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2025 and 2026: Total Liabilities jumped 39.88% in 2025, then slumped 49.81% in 2026.
- Over 5 years, Total Liabilities stood at $25.0 million in 2022, then grew by 5.1% to $26.3 million in 2023, then rose by 14.57% to $30.1 million in 2024, then fell by 26.85% to $22.0 million in 2025, then slipped by 14.35% to $18.9 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $18.9 million, $22.0 million, and $23.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Lexeo Therapeutics | 397.10 Mn | 397.10 Mn | - | 19.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.84 Mn |
| Mar 31, 2026 | 18.86 Mn |
| Dec 31, 2025 | 22.02 Mn |
| Sep 30, 2025 | 23.01 Mn |
| Jun 30, 2025 | 37.85 Mn |
| Mar 31, 2025 | 37.58 Mn |
| Dec 31, 2024 | 30.10 Mn |
| Sep 30, 2024 | 34.54 Mn |
| Jun 30, 2024 | 27.06 Mn |
| Mar 31, 2024 | 30.26 Mn |
| Dec 31, 2023 | 26.27 Mn |
| Sep 30, 2023 | 32.50 Mn |
| Dec 31, 2022 | 25.00 Mn |